BioSpace News Archive

InvestorsObserver issues critical PriceWatch Alerts for IO, MGI, AKBA, IBIO, and XELA.

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2021 results on Tuesday, August 10, 2021.

MorphoSys AG ; announced that its Management Board, with the approval of the Supervisory Board, has passed a resolution to increase the share capital of MorphoSys AG by issuing 1,337,552 new ordinary shares from the Authorized Capital 2021-II, excluding pre-emptive rights of existing shareholders, to implement the purchase of 1,337,552 new ordinary shares by Royalty Pharma Investments 2019 ICAV, a subsidiary of Royalty Pharma plc .

Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering of 6,845,238 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase an additional 892,857 shares, at a public offering price of $42.00 per share.

Ocugen, Inc. announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase an aggregate of 150,750 shares of its common stock and restricted stock units covering an aggregate of 25,250 shares of common stock to seven new employees.

The whole-genome synthesis is a branch of the synthetic biology domain.

In recent years, the drug-compounding industry has embraced United States laws, mandates, and regulatory requirements to ensure reliable, safe, and cost-effective medications to physicians and their patients.

Smart syringe pump is a new technology that assists in the infusion of fluids with added reliability, can be used for controlled pressure, and flow.

Core One Labs Inc. is pleased to announce that it is pursuing a listing on the Capital Market tier of The Nasdaq Stock Market LLC (“ Nasdaq ”) to enhance the Company’s investor profile and increase value for its shareholders.

Visual impairment can be any kind of vision loss, whether it is the condition in which someone cannot see at all or someone has partial vision loss.